DaVita Inc. (DVA) exhibits 45.0% gross margins and 29.2% return on invested capital within Health Care (Misc Health and Biotechnology Services), balanced against a 7.3x enterprise multiple and 4.8% implied options volatility.
Sustained 45.0% gross profitability converts into 15.0% operating margin and 29.2% ROIC, outpacing sector cost of capital.
ROIC: 29.2% // GM: 45.0%YoY revenue trajectory of +6.5% paired with 10.63% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +6.5% // FCF YLD: 10.63%Altman Z-Score of 1.66 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 1.66 // F-SCORE: 8/9Trading at 11.4x trailing P/E (10.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 11.4x // EV/EBITDA: 7.3xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $187.50 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Misc Health and Biotechnology Services require continuous execution to defend 7.9% net margins.
NET MARGIN: 7.9% // D/E: 0.85x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for DVA & activate live FRED threshold breach alerts.